China's pharmaceutical industry

the top think tank for innovation and development

TONACEA CNS Novel Drug Club was established on October 15, 2021 at the First China (Suzhou) Taihu Biomed Innovation Conference. The club gathers leading talents with vision and sense of mission in the field of nervous system R&D to jointly explore the rules of nervous system drug development, to promote the scientific formulation of relevant legal guidelines in China, to train more R&D talents and improve the innovation level of Chinese hospitals. Xiping Xu, the inventor of "Yiye" and the chairman of Shenzhen AUSA PHARMED, is the first president of the club. Yongjun Wang, president of Beijing Tiantan Hospital, is the chief consultant. Dayao Zhao, CEO of Shanghai AffaMed, is the vice president. Peng Wang, deputy director of the State Key Laboratory of Translational Research and Innovative Medicine & CEO of Nanjing NeuroDawn, is the secretary-general of the club. In addition, Rong Chen, Xiaoming Guan, Xiaojiang Li, Zhihong Lu, Guangmei Yan, Xuechu Zhen, Jianzhi Wang and Yuqiang Wang are the directors of the club.

CNS Novel Drug Club

TONACEA CNS Novel Drug Club was established on October 15, 2021 at the First China (Suzhou) Taihu Biomed Innovation Conference. The club gathers leading talents with vision and sense of mission in the field of nervous system R&D to jointly explore the rules of nervous system drug development, to promote the scientific formulation of relevant legal guidelines in China, to train more R&D talents and improve the innovation level of Chinese hospitals. Xiping Xu, the inventor of "Yiye" and the chairman of Shenzhen AUSA PHARMED, is the first president of the club. Yongjun Wang, president of Beijing Tiantan Hospital, is the chief consultant. Dayao Zhao, CEO of Shanghai AffaMed, is the vice president. Peng Wang, deputy director of the State Key Laboratory of Translational Research and Innovative Medicine & CEO of Nanjing NeuroDawn, is the secretary-general of the club. In addition, Rong Chen, Xiaoming Guan, Xiaojiang Li, Zhihong Lu, Guangmei Yan, Xuechu Zhen, Jianzhi Wang and Yuqiang Wang are the directors of the club.

Consultants

TONACEA CNS Novel Drug Club was established on October 15, 2021 at the First China (Suzhou) Taihu Biomed Innovation Conference. The club gathers leading talents with vision and sense of mission in the field of nervous system R&D to jointly explore the rules of nervous system drug development, to promote the scientific formulation of relevant legal guidelines in China, to train more R&D talents and improve the innovation level of Chinese hospitals. Xiping Xu, the inventor of "Yiye" and the chairman of Shenzhen AUSA PHARMED, is the first president of the club. Yongjun Wang, president of Beijing Tiantan Hospital, is the chief consultant. Dayao Zhao, CEO of Shanghai AffaMed, is the vice president. Peng Wang, deputy director of the State Key Laboratory of Translational Research and Innovative Medicine & CEO of Nanjing NeuroDawn, is the secretary-general of the club. In addition, Rong Chen, Xiaoming Guan, Xiaojiang Li, Zhihong Lu, Guangmei Yan, Xuechu Zhen, Jianzhi Wang and Yuqiang Wang are the directors of the club.

Council